MSCTC-0010

N/A

Report date: 2025/05/13 14:40:53

Base Information

Drug NameMSCTC-0010
Drug Alias NameWJ-MSCMSCTC-0010UC-MSCs
ClassificationCell and gene therapy > Cell therapy > Source of cells > Wharton's Jelly-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemiaGraft vs Host DiseaseDiabetes Mellitus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesColombiaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPending
Originator CompaniesNavy General Hospital Pla ChinaUniversity Of Kansas
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Kansas Medical CenterFundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
Inactive CompaniesImac Holdings IncNavy General Hospital Pla China
Active IndicationsIschemiaGraft vs Host DiseaseDiabetes Mellitus
Inactive IndicationsST Elevation Myocardial InfarctionHypokinesia

Other Information

ATC CodeN/A
Related LinksN/A